Here, we observed consistent upregulation of IFNL1 in pregnant and non-pregnant COVID-19 patients compared to controls; yet, consistent with the abovementioned study44, this interferon most strongly contributed to the discrimination of severe/critical cases from controls, suggesting it is most greatly impacted in such patients. The gene discussed is IFNL1; the disease is COVID-19.